UA120764U - THE MEDICINAL PRODUCT OF ANCHESTING AND SPASMOLITIC ACTION "FENTANIL" - Google Patents
THE MEDICINAL PRODUCT OF ANCHESTING AND SPASMOLITIC ACTION "FENTANIL"Info
- Publication number
- UA120764U UA120764U UAU201708006U UAU201708006U UA120764U UA 120764 U UA120764 U UA 120764U UA U201708006 U UAU201708006 U UA U201708006U UA U201708006 U UAU201708006 U UA U201708006U UA 120764 U UA120764 U UA 120764U
- Authority
- UA
- Ukraine
- Prior art keywords
- compound
- formula
- drug
- anchesting
- spasmolitic
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Лікарський препарат знеболювальної та спазмолітичної дії, який включає сполуку за формулою І: EMBED ISISServer (І) або її фармацевтично прийнятну сіль, причому лікарський препарат застосовується у формі розчину для ін'єкцій в концентрації 0,05 мг/мл по 2 мл в ампулах, причому кожна ампула містить 0,1 мг сполуки за формулою І або 0,157 сполуки за формулою 1 у вигляді цитрату, де ампула виготовлена з хімічно стійкого матеріалу, де сполука за формулою І є фентанілом, за умови, що лікарський препарат по суті вільний від іонів двовалентних металів, допоміжні речовини вибирають як щонайменше одну речовину з ряду взаємозамінюваних речовин: кислота хлористоводнева розведена, вода для ін'єкцій, етиловий спирт.An analgesic and antispasmodic drug comprising a compound of Formula I: EMBED ISISServer (I) or a pharmaceutically acceptable salt thereof, the drug being administered as a solution for injection at a concentration of 0.05 mg / ml of 2 ml in ampoules, each ampoule contains 0.1 mg of a compound of formula I or 0.157 of a compound of formula 1 as citrate, wherein the ampoule is made of a chemically stable material, where the compound of formula I is fentanyl, provided that the drug is substantially free of divalent ions metals, auxiliary things owls are selected as at least one substance from a number of interchangeable substances: hydrochloric acid, dilute, water for injection, ethyl alcohol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201708006U UA120764U (en) | 2017-08-01 | 2017-08-01 | THE MEDICINAL PRODUCT OF ANCHESTING AND SPASMOLITIC ACTION "FENTANIL" |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201708006U UA120764U (en) | 2017-08-01 | 2017-08-01 | THE MEDICINAL PRODUCT OF ANCHESTING AND SPASMOLITIC ACTION "FENTANIL" |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA120764U true UA120764U (en) | 2017-11-10 |
Family
ID=60258610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201708006U UA120764U (en) | 2017-08-01 | 2017-08-01 | THE MEDICINAL PRODUCT OF ANCHESTING AND SPASMOLITIC ACTION "FENTANIL" |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA120764U (en) |
-
2017
- 2017-08-01 UA UAU201708006U patent/UA120764U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015029512A2 (en) | pyrazolopyrrolidine derivatives and their use in the treatment of diseases | |
| PH12015502691A1 (en) | Use of high dose pridopidine for treating huntington's disease | |
| EA201491285A1 (en) | IMPROVED COMPOSITIONS AND METHODS OF DELIVERY OF OMEPRAZOL AND ACETYLSALICYLIC ACID | |
| JP2015083580A5 (en) | ||
| NZ631100A (en) | Soft chewable pharmaceutical products | |
| UA107578C2 (en) | COMBINED DIABETES THERAPY | |
| BR112015029401A8 (en) | pyrazolo-pyrrolidin-4-one derivatives, their uses, and pharmaceutical composition and combination | |
| AR036813A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| AR070026A1 (en) | SET OF ELEMENTS FOR THE DOSAGE OF 1-AMINO-ALQUILCICLOHEXANOS, SUCH AS NERAMEXAN, AND TREATMENT OF DIFFERENT DISEASES INCLUDING TINNITUS | |
| NZ595767A (en) | Composition for the treatment of prostate cancer | |
| BR112012030641A2 (en) | methods and compositions for oral pharmaceutical therapy | |
| CY1118158T1 (en) | SECONDARY 1-Piperazine-3-phenyl indians for the therapeutic treatment of schizophrenia | |
| EA202190115A1 (en) | FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS FOR THEIR PREPARATION | |
| WO2018005794A3 (en) | Novel non-systemic tgr5 agonists | |
| EA201070625A1 (en) | DELIVERY SYSTEM OF MEDICINES FOR THE INTRODUCTION OF WATER-SOLUBLE CATION AND AMFILA PHARMACEUTICAL ACTIVE SUBSTANCE | |
| AR046410A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR MODIFIED LIBERATION OF MODAFINILO | |
| PE20130782A1 (en) | PHARMACEUTICAL COMPOSITIONS CONSISTING OF PARACETAMOL AND THE PROCESS FOR THE PREPARATION OF THE SAME | |
| EA201591653A1 (en) | COMPOSITIONS FOR THE TREATMENT OF EYE DISORDERS USING DIPYRIDAMOL | |
| UA120764U (en) | THE MEDICINAL PRODUCT OF ANCHESTING AND SPASMOLITIC ACTION "FENTANIL" | |
| EA201301275A1 (en) | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF PREVENTION AND TREATMENT OF THE ADHESIVE PROCESS | |
| DK2091520T3 (en) | ORAL DOSAGE FORM CONTAINING TRISUBSTITUTED GLYCEROL COMPOUNDS | |
| UA120761U (en) | MORPHIN MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION | |
| RU2014148062A (en) | INJECTION PHARMACEUTICAL COMPOSITION OF DEXKETOPROFEN AND TRAMADOL | |
| BR112014001751A2 (en) | pyrazoline derivatives and their use as selective estrogen receptor modulators | |
| UA120763U (en) | MEDICAL MEDICINAL PRODUCT ANALYTICAL AND SPASMOLITIC ACTION "PROMEDOL" |